NYSE · ENOVHealthcareOrthopedic & Surgical Supplies

Enovis financials

$18.46+1.65%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

QuarterQ2 '26
Jul 3
Q1 '26
Apr 3
Q4 '25
Dec 31
Q3 '25
Oct 3
Q2 '25
Jul 4
Q1 '25
Apr 4
Q4 '24
Dec 31
Q3 '24
Sep 27
Q2 '24
Jun 28
Q1 '24
Mar 29
Q4 '23
Dec 31
Q3 '23
Sep 29
Revenue$582.8M$589.2M$575.8M$548.9M$564.5M$558.8M$561.0M$505.2M$525.2M$516.3M$455.0M$417.5M
Gross profit$359.2M$365.5M$349.4M$328.9M$334.7M$332.2M$307.5M$286.5M$288.9M$297.9M$264.4M$243.0M
Gross margin61.6%62.0%60.7%59.9%59.3%59.5%54.8%56.7%55.0%57.7%58.1%58.2%
Operating income$17.4M$6.5M-$502.2M-$558.5M-$16.8M-$46.8M-$664.7M-$31.7M-$44.2M-$35.0M-$5.8M-$20.5M
Net income-$1.2M-$8.8M-$520.6M-$571.1M-$36.7M-$56.0M-$703.3M-$31.5M-$18.6M-$72.0M$3.0M-$2.9M
Net margin−0.2%−1.5%−90.4%−104.1%−6.5%−10.0%−125.4%−6.2%−3.5%−13.9%0.7%−0.7%
Diluted EPS$-0.02$-0.15$-9.10$-9.99$-0.64$-0.98$-12.58$-0.58$-0.34$-1.32$0.05$-0.05
EBITDA$93.3M$82.6M$79.4M$66.2M$55.5M$28.5M$59.4M$44.6M$26.1M$51.3M-$202.0K$40.3M
Operating cash flow$75.0M$24.0M$88.5M$82.6M$47.8M-$1.6M$88.3M$53.6M$21.2M-$49.6M$68.4M$31.0M
Free cash flow$31.1M-$28.9M$32.3M$29.1M$3.4M-$44.9M$35.1M$2.4M-$18.2M-$86.5M$40.5M$4.0M
Diluted shares57.6M57.3M57.2M57.2M57.1M56.8M55.9M55.7M54.9M54.7M54.6M54.5M

Balance sheet

Period endJul 3Apr 3Dec 31Oct 3Jul 4Apr 4
Cash & equivalents$12.6M$33.1M$36.4M$33.6M$44.1M$38.5M
Short-term investments$0.00$0.00$0.00$0.00$0.00$0.00
Total debt$1.28B$1.33B$1.30B$1.36B$1.39B$1.39B
Total assets$3.77B$3.83B$3.83B$4.43B$5.02B$4.88B
Total liabilities$2.29B$2.35B$2.34B$2.41B$2.44B$2.25B
Shareholders' equity$1.48B$1.48B$1.49B$2.02B$2.58B$2.62B

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology